Conmed (NYSE:CNMD) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.81 by 4.94 percent. This is a 7.59 percent increase over earnings of $0.79 per share from the same period last year. The company reported quarterly sales of $321.30 million which beat the analyst consensus estimate of $313.37 million by 2.53 percent. This is a 2.89 percent increase over sales of $312.27 million the same period last year.